Sort by
Keyphrases
Biomarker Discovery
100%
Neuronal Ceroid Lipofuscinosis
100%
CLN3
69%
Cultured Cells
23%
Drug Screening
15%
Cellular Level
15%
Premature Death
7%
Mouse Model
7%
Vision Loss
7%
Cell Behavior
7%
Proteomics Methods
7%
Lysosomal Storage Disease
7%
Clinical Trials
7%
Long-term Disease
7%
Altered Expression
7%
Multiple Persons
7%
Therapeutic Strategies
7%
Retinal Degeneration
7%
Valuable Insight
7%
Rational Therapeutics
7%
Lymphoblast
7%
Cell-based
7%
Lag behind
7%
Replacement Therapy
7%
Primary Defects
7%
CNS Pathologies
7%
Attenuated Phenotype
7%
Monogenic
7%
Short-term Measures
7%
Drug Validation
7%
Behavioral Deficits
7%
Sample Cell
7%
Progressive Neurodegeneration
7%
Seizure
7%
Transmembrane Protein
7%
Mutant Mice
7%
Treatment Regimen
7%
Fibroblasts
7%
Clinical Rating Scale
7%
Mental Deterioration
7%
Proteomics
7%
Responsive Proteins
7%
Pathophysiology
7%
Drug Screen
7%
Human Induced Pluripotent Stem Cell-derived Neurons
7%
Older Adults
7%
Disease Progression
7%
Knock-in Mouse Model
7%
Protein Changes
7%
Biochemistry, Genetics and Molecular Biology
Biomarker Discovery
100%
Neuronal Ceroid Lipofuscinosis
100%
Batten Disease
100%
CLN3
53%
Mouse Model
15%
Drug Screening
15%
Proteomics
15%
Lysosomal Storage Disease
7%
Clinical Trial
7%
Lymphoblast
7%
Cell Function
7%
Induced Pluripotent Stem Cell
7%
Knockout Mouse
7%
Mouse Mutant
7%
Transmembrane Protein
7%
Membrane Protein
7%
Omeprazole
7%
Fibroblast
7%
Medicine and Dentistry
Batten Disease
100%
Biological Marker
100%
Drug Screening
15%
Proteomics
15%
Diseases
15%
Neurodegeneration
7%
Disease Exacerbation
7%
Retina Degeneration
7%
Epileptic Seizure
7%
Substitution Therapy
7%
Prematurity
7%
Mental Deterioration
7%
Omeprazole
7%
In Vitro
7%
Lymphoblast
7%
Pathophysiology
7%
Clinical Trial
7%
Membrane Protein
7%
Cell Line
7%
Lysosomal Storage Disease
7%
Cell Function
7%
Induced Pluripotent Stem Cell
7%
Cerebrospinal Fluid
7%
Rating Scale
7%
Fibroblast
7%